Filing Details
- Accession Number:
- 0001181431-12-060719
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-27 18:27:22
- Reporting Period:
- 2012-11-26
- Filing Date:
- 2012-11-27
- Accepted Time:
- 2012-11-27 18:27:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113148 | Infinity Pharmaceuticals Inc. | INFI | Pharmaceutical Preparations (2834) | 330655706 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1378796 | M Christopher Lindblom | C/O Infinity Pharmaceuticals, Inc. 780 Memorial Drive Cambridge MA 02139 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-11-26 | 10,000 | $14.33 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-11-26 | 3,885 | $9.80 | 13,885 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-26 | 13,885 | $25.73 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2012-11-26 | 10,000 | $0.00 | 10,000 | $14.33 |
| Common Stock | Stock Option (right to buy) | Disposition | 2012-11-26 | 3,885 | $0.00 | 3,885 | $9.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,000 | 2016-10-26 | No | 4 | M | Direct | |
| 0 | 2017-12-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,158 | Indirect | 401(k) |
Footnotes
- Represents 2,158 shares of Infinity Pharmaceuticals, Inc. common stock acquired under the Infinity Pharmaceuticals, Inc. 401(k) plan.
- This option was fully vested with respect to all 20,000 shares subject to the option as of the date hereof.
- This option was fully vested with respect to all 3,885 shares subject to the option as of the date hereof.
Billionaire Hedge Funds
